SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-048030
Filing Date
2024-05-30
Accepted
2024-05-30 16:51:35
Documents
14
Period of Report
2024-05-30
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ea020712501-8k_biomxinc.htm   iXBRL 8-K 35540
  Complete submission text file 0001213900-24-048030.txt   256175

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE phge-20240530.xsd EX-101.SCH 3805
3 XBRL DEFINITION FILE phge-20240530_def.xml EX-101.DEF 26681
4 XBRL LABEL FILE phge-20240530_lab.xml EX-101.LAB 36834
5 XBRL PRESENTATION FILE phge-20240530_pre.xml EX-101.PRE 25305
17 EXTRACTED XBRL INSTANCE DOCUMENT ea020712501-8k_biomxinc_htm.xml XML 5805
Mailing Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38762 | Film No.: 241006260
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)